A phase 3 study of first-line sotorasib, panitumumab, and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb for patients with <i>KRAS </i>G12C-mutated metastatic colorectal cancer (CodeBreaK 301).

---

Kim T. W., Price T., Grasselli J., Masuishi T., Kwok G. W., Yalcin S., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, sa.4_SUPPL, 2025 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Basım Tarihi: 2025
• Doi Numarası: 10.1200/jco.2025.43.4_suppl.tps326
• Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database, Nature Index
• Hacettepe Üniversitesi Adresli: Evet